心脏磁共振评估慢性阻塞性肺疾病合并肺动脉高压的肺动脉血流动力学与右心室功能
该研究纳入宁夏医科大学总医院呼吸与危重症学科2013年10月至2016年10月诊断的37例COPD患者,经胸超声心动图测PASP>40 mmHg定义为PAH并分为COPD组与COPD+PAH组,1周内完成肺功能、血气分析、CMRI及6分钟步行试验。16例合并PAH。两组FEV1/FVC、FEV1pred、PaO2、PaCO2等基线无显著差异;COPD+PAH组mPAD、RVEF、6MWD显著低于COPD组,mPAP、RVMED、RVMES显著高于COPD组,LVEF无显著差异。COPD组中2例TTE测PASP正常(<40 mmHg)而CMRI测mPAP高于正常上限(>25 mmHg)。作者认为CMRI可早期监测COPD患者肺动脉血流动力学和右心功能变化。
要点
- 37例COPD患者中16例合并PAH;COPD+PAH组mPAP 28.89±3.16 mmHg vs COPD组20.18±2.43 mmHg,显著升高(P<0.01)。
- COPD+PAH组RVEF 0.525±0.054 vs COPD组0.592±0.071,显著降低(P<0.01);两组LVEF无显著差异(0.663±0.082 vs 0.699±0.075,P>0.05)。
- COPD+PAH组6MWD 319.3±116.5 m vs COPD组408.2±38.0 m,显著降低(P<0.01)。
- COPD组中2例TTE测PASP正常(<40 mmHg)而CMRI测mPAP高于正常上限(>25 mmHg)。
- RVMED与PaO2负相关(r=-0.581,P=0.015)、与PaCO2正相关(r=0.592,P=0.014);6MWD与RVEF正相关(r=0.485,P=0.041)。
适用人群与场景
- 2013年10月至2016年10月宁夏医科大学总医院呼吸与危重症学科诊断的37例COPD患者,均完成经胸超声心动图测PASP。
- 按是否存在PAH分为COPD组与COPD+PAH组,PAH定义为PASP>40 mmHg(1 mmHg=0.133 kPa)。
诊断标准与关键阈值
- PAH诊断标准:经胸超声心动图测肺动脉收缩压(PASP)>40 mmHg(1 mmHg=0.133 kPa)定义为PAH。
- CMRI测平均肺动脉压(mPAP)正常上限为25 mmHg,>25 mmHg为高于正常上限。
研究设计与关键结果
- 研究类型为单中心队列研究,纳入37例COPD患者,其中16例合并PAH;两组FEV1/FVC、FEV1pred、PaO2、PaCO2等基线指标无显著差异。
- COPD+PAH组mPAD(25.64±5.01)% vs COPD组(44.00±22.52)%、RVEF 0.525±0.054 vs 0.592±0.071、6MWD 319.3±116.5 m vs 408.2±38.0 m,均显著降低(P<0.01)。
- COPD+PAH组mPAP 28.89±3.16 mmHg vs COPD组20.18±2.43 mmHg、RVMED 57.19±15.46 g vs 40.71±15.44 g、RVMES 45.99±11.16 g vs 33.71±13.39 g,均显著升高(P<0.01)。
- 两组LVEF无显著差异(0.663±0.082 vs 0.699±0.075,P>0.05)。
- COPD组中2例TTE测PASP正常(PSAP<40 mmHg),而CMRI测mPAP高于正常上限(>25 mmHg)。
- 相关性分析:mPAD与FEV1/FVC正相关(r1=0.538,P1=0.021)、与FEV1pred正相关(r2=0.448,P2=0.049);RVMED与PaO2负相关(r=-0.581,P=0.015)、与PaCO2正相关(r=0.592,P=0.014);6MWD与RVEF正相关(r=0.485,P=0.041),与LVEF无相关性(r=0.271,P=0.104)。
证据类型、等级与局限
- 证据类型:单中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与COPD患者相比,COPD合并PAH患者的肺动脉血流动力学与右心室功能变化与气流受限严重程度相关。
- 作者认为,CMRI可早期监测COPD患者肺动脉血流动力学和右心功能变化;一旦出现PAH,肺动脉血流动力学、右心功能和运动耐量均已发生变化。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the role of cardiac magnetic resonance imaging (CMRI) in evaluating pulmonary hemodynamics and right ventricular function in patients with chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PAH); and the relationship between CMRI parameters and pulmonary function parameters, blood gas analysis parameters and 6-minute walk test (6MWT) parameters in patients with COPD complicated with PAH.
METHODS: Thirty-seven patients were diagnosed with COPD in the department of respiratory and critical care discipline of Ningxia Medical University General Hospital from October 2013 to October 2016, who underwent transthoracic echocardiography (TTE) to measure pulmonary arterial systolic pressure (PASP), and were divided into COPD group and COPD+PAH group according to whether there was PAH [PASP > 40 mmHg (1 mmHg = 0.133 kPa) was defined as PAH]. All patients completed pulmonary function tests [1 second forced expiratory volume to forced vital capacity ratio (FEV1/FVC), FEV1 predicted value (FEV1pred)], blood gas analysis [arterial blood oxygen partial pressure (PaO2), arterial blood carbon dioxide partial pressure (PaCO2)], CMRI examination [relative dilatation of the main pulmonary artery (mPAD), mean pulmonary artery pressure (mPAP), left ventricular ejection fraction (LVEF), right ventricular ejection fraction (RVEF), right ventricular end-diastolic myocardial mass (RVMED), right ventricular end-systolic myocardial mass (RVMES)], and 6MWD [6-minute walk distance (6MWD)] within 1 week. The obtained clinical parameters had been compared between the groups, and correlation was analyzed.
RESULTS: Among the 37 patients with COPD, 16 patients were complicated with PAH. There were no significant differences in FEV1/FVC, FEV1pred, PaO2, PaCO2 and other baseline indicators between the two groups. In the COPD group, TTE obtained PASP of 2 patients were normal (PSAP < 40 mmHg), while CMRI measured mPAP were higher than the normal limit (> 25 mmHg). Compared with the COPD group, mPAD, RVEF and 6MWD were significantly decreased in the COPD+PAH group [mPAD: (25.64±5.01)% vs. (44.00±22.52)%, RVEF: 0.525±0.054 vs. 0.592±0.071, 6MWD (m): 319.3±116.5 vs. 408.2±38.0, all P < 0.01], mPAP, RVMED and RVMES were significantly increased [mPAP (mmHg): 28.89±3.16 vs. 20.18±2.43, RVMED (g): 57.19±15.46 vs. 40.71±15.44, RVMES (g): 45.99±11.16 vs. 33.71±13.39, all P < 0.01], and there was no significant differences in LVEF (0.663±0.082 vs. 0.699±0.075, P > 0.05). Correlation analysis showed that mPAD was positively correlated with FEV1/FVC and FEV1pred (r1 = 0.538, P1 = 0.021; r2 = 0.448, P2 = 0.049); RVMED was negatively correlated with PaO2 (r = -0.581, P = 0.015), and positively correlated with PaCO2 (r = 0.592, P = 0.014); 6MWD was positively correlated with RVEF (r = 0.485, P = 0.041), and had no correlation with LVEF (r = 0.271, P = 0.104).
CONCLUSIONS: Compared with COPD patients, changes in pulmonary hemodynamics and right ventricular function in COPD patients with PAH are related to the severity of airflow limitation. CMRI can early monitor pulmonary hemodynamics and right heart function changes in patients with COPD. Once PAH appears, pulmonary hemodynamics, right heart function and exercise tolerance have changed.
参考来源
- Fan Y, Guo X, Sun X, et al. [Assessment of the hemodynamics of pulmonary artery and right ventricular function in chronic obstructive pulmonary disease with pulmonary hypertension using cardiac magnetic resonance imaging]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31537222. doi:10.3760/cma.j.issn.2095-4352.2019.08.012
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。